Looking Into Applied DNA Sciences's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Applied DNA Sciences (NYSE:APDN) has seen a significant increase in short interest, rising 142.36% since its last report. The company now has 1.73 million shares sold short, representing 16.82% of its float. This is notably higher than its peers' average short interest of 4.20%.
September 10, 2024 | 4:45 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Applied DNA Sciences has experienced a 142.36% increase in short interest, with 16.82% of its shares sold short. This high level of short interest compared to peers may indicate bearish sentiment but could also lead to a short squeeze if the stock price rises.
The significant increase in short interest suggests bearish sentiment towards APDN. However, high short interest can also lead to a short squeeze if the stock price rises, creating potential volatility. The comparison with peers highlights the unusually high short interest, which is a critical factor for investors to consider.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100